Roy Beck, MD, PhD
Articles
July 2nd 2013
Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
Michael E. Chernew, PhD Rick McKellar, BS Wade Aubry, MD Roy Beck, MD, PhD Joshua Benner, PharmD, ScD Jan E. Berger, MD, MJ A. Mark Fendrick, MD Felicia Forma, BSc Dana Goldman, PhD Anne Peters, MD Rebecca Killion, MA Darius Lakdawalla, PhD Douglas K. Owens, MD Joe Stahl, MA
February 12th 2013
Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
Michael E. Chernew, PhD Rick McKellar, BS Wade Aubry, MD Roy Beck, MD, PhD Joshua Benner, PharmD, ScD Jan E. Berger, MD, MJ A. Mark Fendrick, MD Felicia Forma, BSc Dana Goldman, PhD Anne Peters, MD Rebecca Killion, MA Darius Lakdawalla, PhD Douglas K. Owens, MD Joe Stahl, MA
Formularies of the future should use evidence-produced CER to better target, not limit, diabetes care.
Latest Updated Articles
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: July 24th 2024 | Updated: July 27th 2024
Long-Term Follow-Up from CheckMate 9LA at ASCO 2024
Published: July 24th 2024 | Updated: July 27th 2024
Insights from the TROPION-Lung05 Trial at ASCO 2024
Published: July 24th 2024 | Updated: July 27th 2024
Examining Trends, Future Directions in AI and Health Care
Published: July 15th 2024 | Updated: July 27th 2024
No Sex Differences Identified in Aspirin Dosing for Secondary Prevention of ASCVD
Published: July 24th 2024 | Updated: July 27th 2024
Future Directions in the Management of Multiple Myeloma
